| 0 (0%) | 11-11 15:53 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.9 |
1-year : | 0.96 |
| Resists | First : | 0.77 |
Second : | 0.82 |
| Pivot price | 0.75 |
|||
| Supports | First : | 0.68 | Second : | 0.57 |
| MAs | MA(5) : | 0.74 |
MA(20) : | 0.76 |
| MA(100) : | 0.73 |
MA(250) : | 0.86 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 39.7 |
D(3) : | 51.6 |
| RSI | RSI(14): 36.8 |
|||
| 52-week | High : | 2.06 | Low : | 0.32 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ MGTA ] has closed below the lower bollinger band by 19.5%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 30.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.76 - 0.76 | 0.76 - 0.77 |
| Low: | 0.68 - 0.69 | 0.69 - 0.69 |
| Close: | 0.69 - 0.7 | 0.7 - 0.71 |
Tue, 23 Sep 2025
MGTA Fall Class Registration Classes - Prince William Living
Mon, 23 Jun 2025
P-type ATPase magnesium transporter MgtA acts as a dimer - Nature
Fri, 28 Jul 2023
Magenta Therapeutics: Potential Upside In The Merger, Wait To Buy More (MGTA) - Seeking Alpha
Mon, 30 Jan 2023
Investigators Pause Trial for MGTA-117 in Relapsed/Refractory AML and MDS - CancerNetwork
Thu, 26 Jan 2023
Magenta halts study of targeted conditioning drug after participant’s death - BioPharma Dive
Thu, 26 Jan 2023
After dose de-escalation, death drives Magenta to pause antibody-drug conjugate leukemia trial - Fierce Biotech
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 61 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 2.2 (%) |
| Held by Institutions | 62.6 (%) |
| Shares Short | 383 (K) |
| Shares Short P.Month | 393 (K) |
| EPS | -1.15 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.24 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -28.9 % |
| Return on Equity (ttm) | -65.4 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.95 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -73 (M) |
| Levered Free Cash Flow | -30 (M) |
| PE Ratio | -0.61 |
| PEG Ratio | 0 |
| Price to Book value | 0.56 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.59 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|